Published in Nature on January 03, 2001
Tau suppression in a neurodegenerative mouse model improves memory function. Science (2005) 8.66
Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci (2010) 5.27
Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res (2006) 4.15
Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci (2010) 3.36
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci (2010) 2.99
Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natl Acad Sci U S A (2004) 2.56
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest (2004) 2.52
Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A (2006) 2.51
Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci (2011) 2.47
Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron (2010) 2.10
Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol (2007) 2.09
Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci (2005) 2.03
Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid. Int Immunol (2003) 2.02
Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci U S A (2003) 1.86
The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med (2010) 1.86
AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice. Proc Natl Acad Sci U S A (2006) 1.74
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther (2009) 1.67
Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci (2010) 1.66
What is the Most Sensitive Measure of Water Maze Probe Test Performance? Front Integr Neurosci (2009) 1.56
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet (2014) 1.56
Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain (2008) 1.42
Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques. Proc Natl Acad Sci U S A (2001) 1.41
Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury. Exp Neurol (2005) 1.38
Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A (2004) 1.36
Search strategies used by APP transgenic mice during navigation in the Morris water maze. Learn Mem (2004) 1.35
Overexpression of motor protein KIF17 enhances spatial and working memory in transgenic mice. Proc Natl Acad Sci U S A (2002) 1.33
Effects of fetal exposure to isoflurane on postnatal memory and learning in rats. Neuropharmacology (2007) 1.31
Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice. J Neurosci (2007) 1.31
Anti-A beta 1-11 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers. J Biol Chem (2007) 1.30
Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci (2008) 1.30
Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease. Neurobiol Dis (2008) 1.29
The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J (2006) 1.29
Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice. FASEB J (2010) 1.29
Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem (2007) 1.22
Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau. EMBO J (2007) 1.22
Transgenic models of Alzheimer's disease: learning from animals. NeuroRx (2005) 1.21
Mouse models of Alzheimer's disease. Brain Res Bull (2011) 1.19
Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J Cell Mol Med (2008) 1.16
Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment. Exp Neurol (2007) 1.16
CREB binding protein is required for both short-term and long-term memory formation. J Neurosci (2010) 1.14
Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664. Behav Brain Res (2008) 1.12
Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene. Eur J Immunol (2003) 1.12
Motor coordination deficits in mice lacking RGS9. Brain Res (2007) 1.11
Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits. J Neurosci (2008) 1.11
Transgenic mouse models of Alzheimer's disease. Mt Sinai J Med (2010) 1.09
Ca-stimulated type 8 adenylyl cyclase is required for rapid acquisition of novel spatial information and for working/episodic-like memory. J Neurosci (2008) 1.09
Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model. Proc Natl Acad Sci U S A (2008) 1.09
Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch. Vaccine (2005) 1.09
Amyloid-beta protofibril levels correlate with spatial learning in Arctic Alzheimer's disease transgenic mice. FEBS J (2009) 1.08
Increasing CREB function in the CA1 region of dorsal hippocampus rescues the spatial memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology (2011) 1.08
Deregulated Cdk5 activity is involved in inducing Alzheimer's disease. Arch Med Res (2012) 1.08
Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer's disease. PLoS One (2009) 1.07
Abeta-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer's disease mice. Mol Ther (2010) 1.06
Transgenic nonhuman primates for neurodegenerative diseases. Reprod Biol Endocrinol (2004) 1.06
Mechanisms underlying basal and learning-related intrinsic excitability in a mouse model of Alzheimer's disease. Neurobiol Aging (2009) 1.06
Spines, plasticity, and cognition in Alzheimer's model mice. Neural Plast (2011) 1.06
Tau oligomers impair artificial membrane integrity and cellular viability. J Biol Chem (2012) 1.03
Alzheimer's therapeutics: translation of preclinical science to clinical drug development. Neuropsychopharmacology (2011) 1.02
Synaptic plasticity defect following visual deprivation in Alzheimer's disease model transgenic mice. J Neurosci (2012) 1.02
COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo. Neurogenetics (2009) 1.01
Faster forgetting contributes to impaired spatial memory in the PDAPP mouse: deficit in memory retrieval associated with increased sensitivity to interference? Learn Mem (2008) 1.00
Fas ligand-mediated apoptosis in degenerative disorders of the brain. J Clin Immunol (2003) 0.99
Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease. Alzheimers Res Ther (2013) 0.97
Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice. J Neuroinflammation (2008) 0.97
Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease. Prion (2012) 0.97
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo) (2011) 0.96
c-Jun N-terminal kinase regulates soluble Aβ oligomers and cognitive impairment in AD mouse model. J Biol Chem (2011) 0.96
Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis. J Neurosci (2013) 0.95
Effects of Glycyrrhizae Radix on Repeated Restraint Stress-induced Neurochemical and Behavioral Responses. Korean J Physiol Pharmacol (2010) 0.95
An update of animal models of Alzheimer disease with a reevaluation of plaque depositions. Exp Neurobiol (2013) 0.95
Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model. Mol Neurodegener (2010) 0.94
Modulation of murine Alzheimer pathogenesis and behavior by surgery. Ann Surg (2013) 0.94
Reversal of learning deficits in hAPP transgenic mice carrying a mutation at Asp664: a role for early experience. Behav Brain Res (2009) 0.94
Progress and prospects for genetic modification of nonhuman primate models in biomedical research. ILAR J (2013) 0.93
Rapamycin promotes beta-amyloid production via ADAM-10 inhibition. Biochem Biophys Res Commun (2010) 0.93
Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor. Exp Neurol (2009) 0.92
Btg1 is Required to Maintain the Pool of Stem and Progenitor Cells of the Dentate Gyrus and Subventricular Zone. Front Neurosci (2012) 0.92
Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice. Mol Neurodegener (2012) 0.92
Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology. PLoS One (2013) 0.90
The immunotherapy of Alzheimer's disease. Immun Ageing (2004) 0.90
Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice. J Neurochem (2013) 0.89
False recognition in a mouse model of Alzheimer's disease: rescue with sensory restriction and memantine. Brain (2012) 0.89
A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease. Alzheimers Dement (2015) 0.89
Glycation exacerbates the neuronal toxicity of β-amyloid. Cell Death Dis (2013) 0.88
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory. Neuropsychopharmacology (2010) 0.88
Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome. PLoS One (2014) 0.87
Cholesterol enhances classical conditioning of the rabbit heart rate response. Behav Brain Res (2007) 0.87
Age-related increase in amyloid plaque burden is associated with impairment in conditioned fear memory in CRND8 mouse model of amyloidosis. Alzheimers Res Ther (2012) 0.87
FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice. Int J Dev Neurosci (2008) 0.87
Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease. Cell Cycle (2014) 0.85
Behavioral deficits and subregion-specific suppression of LTP in mice expressing a population of mutant NMDA receptors throughout the hippocampus. Learn Mem (2009) 0.85
Growth factors in synaptic function. Front Synaptic Neurosci (2013) 0.85
Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment. Learn Mem (2006) 0.85
(-)-Epigallocatechin-3-gallate ameliorates learning and memory deficits by adjusting the balance of TrkA/p75NTR signaling in APP/PS1 transgenic mice. Mol Neurobiol (2013) 0.84
Spatial memory: behavioral determinants of persistence in the watermaze delayed matching-to-place task. Learn Mem (2013) 0.84
S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model. PLoS One (2014) 0.84
Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 mice. PLoS One (2013) 0.83
Classical conditioning of the rabbit's nictitating membrane response is a function of the duration of dietary cholesterol. Nutr Neurosci (2007) 0.83
Neuroprotective Effect of Lucium chinense Fruit on Trimethyltin-Induced Learning and Memory Deficits in the Rats. Exp Neurobiol (2011) 0.83
Advances on the understanding of the origins of synaptic pathology in AD. Curr Genomics (2007) 0.83
Place navigation impaired in rats with hippocampal lesions. Nature (1982) 15.79
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 12.95
Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science (1996) 12.23
Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (1993) 10.72
High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci (2000) 9.85
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 8.89
Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci (2000) 8.20
Synaptic tagging and long-term potentiation. Nature (1997) 7.65
Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature (1986) 7.10
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (1995) 6.85
Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol (1984) 6.67
Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature (1992) 6.51
Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature (1998) 6.29
Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol (1999) 6.24
Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature (1999) 5.77
Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A (1999) 5.75
Apoptosis. The role of the endonuclease. Am J Pathol (1990) 5.43
Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood (2001) 5.23
Inhibition of Bax channel-forming activity by Bcl-2. Science (1997) 5.10
Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci U S A (1997) 4.92
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem (2001) 4.45
Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs. Clin Med (2003) 4.01
Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem (2000) 3.85
TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med (2001) 3.84
Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat Genet (2000) 3.80
Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Hippocampus (1999) 3.55
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Spatial learning with a minislab in the dorsal hippocampus. Proc Natl Acad Sci U S A (1995) 3.42
Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology (2001) 3.30
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet (2003) 3.23
Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J Cogn Neurosci (2004) 3.10
Synaptic tagging: implications for late maintenance of hippocampal long-term potentiation. Trends Neurosci (1998) 3.00
Distribution and significance of fecal indicator organisms in the Upper Chesapeake Bay. Appl Microbiol (1975) 2.99
Memory consolidation and NMDA receptors: discrepancy between genetic and pharmacological approaches. Science (2001) 2.97
Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci (1997) 2.91
Renal effects of cadmium body burden of the general population. Lancet (1990) 2.90
The CASBAH: a searchable database of caspase substrates. Cell Death Differ (2007) 2.89
Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell (1994) 2.88
Molecular cloning and expression of the mouse ornithine decarboxylase gene. Proc Natl Acad Sci U S A (1984) 2.83
Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif (1991) 2.81
Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology (2005) 2.79
Patterned delivery of immunoglobulins to surfaces using microfluidic networks. Science (1997) 2.79
Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology (1985) 2.77
BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet (2001) 2.76
Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat Med (2001) 2.75
Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci (1996) 2.69
Young people, alcohol, and designer drinks: quantitative and qualitative study. BMJ (1997) 2.64
The ribonucleic acids of the infective and interfering components of vesicular stomatitis virus. J Gen Virol (1967) 2.57
Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature (1995) 2.47
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A (1998) 2.46
Comparison of multilocus sequence typing and pulsed-field gel electrophoresis as tools for typing Staphylococcus aureus isolates in a microepidemiological setting. J Clin Microbiol (2002) 2.45
CD44 contributes to T cell activation. J Immunol (1989) 2.44
White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology (2006) 2.42
The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ (2002) 2.42
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol (1997) 2.38
Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J (1997) 2.35
Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Philos Trans R Soc Lond B Biol Sci (2003) 2.34
Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat Neurosci (1999) 2.32
Changes in emotion after circumscribed surgical lesions of the orbitofrontal and cingulate cortices. Brain (2003) 2.32
Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med (1999) 2.32
The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol (1995) 2.32
Benign oesophageal stricture: the place of surgery in the management of elderly patients. Age Ageing (1990) 2.32
A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain (1988) 2.32
Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation (1995) 2.24
Impaired spatial learning after saturation of long-term potentiation. Science (1998) 2.17
Quality of life of elderly people after surgery for benign oesophageal stricture. BMJ (1989) 2.16
Functional magnetic resonance imaging of synesthesia: activation of V4/V8 by spoken words. Nat Neurosci (2002) 2.05
Hippocampal representation in place learning. J Neurosci (1990) 2.05
Hormone-induced cell death. Purification ad properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol (1982) 2.04
The enigma of olfactory learning. Trends Neurosci (1993) 2.02
Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J Neurosci (1997) 2.01
Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Hum Brain Mapp (1999) 2.01
The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci (2001) 2.01
Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature (1997) 1.99
Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation (1999) 1.97
Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ (1999) 1.97
Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci U S A (1993) 1.96
Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J Biol Chem (1995) 1.95
Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release. Cell Death Differ (2000) 1.92
A structural equation modeling investigation of age-related variance in executive function and DTI measured white matter damage. Neurobiol Aging (2007) 1.92
Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer. Oncogene (1996) 1.89
Geriatric medicine in Hull: a comprehensive service. Br Med J (1977) 1.88
Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J (2001) 1.88
Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia (1989) 1.87
Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol (2001) 1.85
Renal excretion of proteins and enzymes in workers exposed to cadmium. Eur J Clin Invest (1979) 1.85
Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol (1998) 1.84
Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis. Am J Pathol (1984) 1.83
In vivo measurement of liver and kidney cadmium in workers exposed to this metal: its significance with respect to cadmium in blood and urine. Environ Res (1981) 1.81
Assessment of renal function of workers exposed to inorganic lead, calcium or mercury vapor. J Occup Med (1980) 1.80
Incidence of Salmonella spp., Clostridium botulinum, and Vibrio parahaemolyticus in an estuary. Appl Environ Microbiol (1976) 1.80
The ica operon and biofilm production in coagulase-negative Staphylococci associated with carriage and disease in a neonatal intensive care unit. J Clin Microbiol (2002) 1.77
Overexpression of tau in a nonneuronal cell induces long cellular processes. J Cell Biol (1991) 1.77
The functional neuroanatomy of comprehension and memory: the importance of prior knowledge. Brain (1999) 1.74
Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res (1999) 1.73